Sibrotuzumab

http://dbpedia.org/resource/Sibrotuzumab an entity of type: Thing

Sibrotuzumab is a humanized monoclonal antibody intended for the treatment of cancer. It binds to FAP In 2003 it failed a phase II clinical trial for metastatic colorectal cancer. rdf:langString

Il sibrotuzumab è un anticorpo monoclonale umanizzato ricombinante studiato per il trattamento di forme di tumore. Si lega ed agisce sulla proteina attivatore del fibroblata FAP. rdf:langString

rdfs:label

rdf:langString Sibrotuzumab

dbpedia-owl:wikiPageID

xsd:integer 9685939

dbpedia-owl:wikiPageRevisionID

xsd:integer 1003464281

dbpprop:atcPrefix

rdf:langString none

dbpprop:casNumber

xsd:integer 216669

dbpprop:chemspiderid

rdf:langString none

dbpprop:source

rdf:langString zu/o

dbpprop:type

rdf:langString mab

dbpprop:unii

xsd:integer 552

dbpprop:verifiedfields

rdf:langString changed

dbpprop:verifiedrevid

xsd:integer 464389928

dbpedia-owl:abstract

rdf:langString Sibrotuzumab is a humanized monoclonal antibody intended for the treatment of cancer. It binds to FAP In 2003 it failed a phase II clinical trial for metastatic colorectal cancer.

rdf:langString Il sibrotuzumab è un anticorpo monoclonale umanizzato ricombinante studiato per il trattamento di forme di tumore. Si lega ed agisce sulla proteina attivatore del fibroblata FAP.

dbpprop:mabType

rdf:langString mab

dbpedia-owl:wikiPageLength

xsd:nonNegativeInteger 2824

dbpedia-owl:casNumber

xsd:string 216669-97-5

dbpedia-owl:fdaUniiCode

xsd:string 552U6E1NIW

rdf:type

owl:Thing

<http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject>

dbpedia-owl:ChemicalSubstance